[Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker]. [electronic resource]
Producer: 20090508Description: 23-7 p. digitalISSN:- 0213-005X
- Adult
- Benzoates -- adverse effects
- CCR5 Receptor Antagonists
- Chemical and Drug Induced Liver Injury -- etiology
- Clinical Trials as Topic -- statistics & numerical data
- Comorbidity
- Cyclohexanes -- adverse effects
- Diketopiperazines
- Disease Susceptibility
- Drug Design
- HIV Fusion Inhibitors -- adverse effects
- HIV Infections -- drug therapy
- Homozygote
- Humans
- Hyperlipidemias -- epidemiology
- Incidence
- Infections -- epidemiology
- Maraviroc
- Membrane Fusion -- drug effects
- Neoplasms -- epidemiology
- Piperazines -- adverse effects
- Receptors, CCR5 -- genetics
- Sequence Deletion
- Spiro Compounds -- adverse effects
- Triazoles -- adverse effects
- Virus Attachment -- drug effects
- Virus Internalization -- drug effects
- env Gene Products, Human Immunodeficiency Virus -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.